Hydrophobically-modified let-7b miRNA enhances biodistribution to NSCLC and downregulates HMGA2 in vivo

Abstract MicroRNAs 1 have increasingly been shown to be involved in human cancer and interest has grown about the potential use of miRNAs for cancer therapy. MiRNA levels are known to be altered in cancer cells, including in non-small cell lung cancer (NSCLC), a subtype of lung cancer that is the most prevalent form of cancer worldwide and which lacks effective therapies. The let-7 miRNA is involved in the regulation of oncogene expression in cells and directly represses cancer growth in the lung. let-7 is therefore, a potential molecular target for tumor therapy. However, applications of RNA interference for cancer research have been limited by a lack of simple and efficient methods to deliver oligonucleotides to cancer cells. Here we have used in vitro and in vivo approaches to show that HCC827 cells internalize hydrophobically-modified let-7b miRNAs (hmiRNAs) added directly to the culture medium without the need for lipid formulation. We identified functional let-7b hmiRNAs targeting the HMGA2 mRNA, one of the let-7 target genes upregulated in NSCLC2-6 and show that direct uptake in HCC827 cells induced potent and specific gene silencing in vitro and in vivo. Thus, hmiRNAs constitute a novel class of oligonucleotides (ONs) that enable functional studies of genes involved in cancer biology and are potentially therapeutic molecules.